Fig. 1From: Carrier-free multifunctional nanomedicine for intraperitoneal disseminated ovarian cancer therapyCharacterizations of ACaT nanomedicine. A Schematic representation, B TEM images, C size distribution, D XRD pattern, and E FTIR spectra of alendronate sodium, THZ1 and ACaT. F Degradation of ACaT nanoparticles in PBS at different pH values. G Stability of ACaT nanomedicine in different mediaBack to article page